Dissecting inflammation in ESRD: Do cytokines and C-reactive protein have a complementary prognostic value for mortality in dialysis patients?

Journal of the American Society of Nephrology

Volumn 17, Issue SUPPL. 3, 2006, Pages

  Zoccali, Carmine ^a,b,c   Tripepi, Giovanni ^b   Mallamaci, Francesca ^a,b  

^a BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

^b CNR IBIM Clinical Epidemiology of Renal Diseases and Hypertension   (Italy)

^c CNR Consiglio Nazionale delle Ricerche   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ATHEROGENESIS; ATHEROSCLEROSIS; BAYES THEOREM; CONFERENCE PAPER; DIALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT;

EID: 33845268461     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006080910     Document Type: Conference Paper

References (21)

1. Tripepi G, Mallamaci F, Zoccali C: Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: Searching for the best risk marker by multivariate modeling. J Am Soc Nephrol 16 [Suppl 1]: S83-S88, 2005
2. Armstrong EJ, Morrow DA, Sabatine MS: Inflammatory biomarkers in acute coronary syndromes: Part I - Introduction and cytokines. Circulation 113: e72-e75, 2006
3. Ross R: Atherosclerosis: An inflammatory disease. N Engl J Med 340: 115-126, 1999
4. Zoccali C, Bode-Boger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, Cataliotti A, Bellanuova I, Fermo I, Frolich J, Boger R: Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study. Lancet 358: 2113-2117, 2001
5. Mallamaci F, Zoccali C, Tripepi G, Fermo I, Benedetto FA, Cataliotti A, Bellanuova I, Malatino LS, Soldarini A: Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int 61: 609-614, 2002
6. Collet D: Modelling Survival Data in Medical Research. Tests in Statistical Science, London, Chapman & Hall, 1994, pp 72-85
7. Altman DG: Two further ways for looking at diagnostic tests: The likelihood ratio and the ROC curve. In: Practical Statistics for Medical Research, edited by Altman DG, London, Chapman & Hall, 1991, pp 416-418
8. Zoccali C, Mallamaci F, Tripepi G: Inflammation and atherosclerosis in end stage renal disease. Blood Purif 21: 29-36, 2003
9. Armstrong EJ, Morrow DA, Sabatine MS: Inflammatory biomarkers in acute coronary syndromes: Part II - Acute-phase reactants and biomarkers of endothelial cell activation. Circulation 113: e152-e155, 2006
10. Verschuur M, de Jong M, Felida L, de Maat MP, Vos HL: A hepatocyte nuclear factor-3 site in the fibrinogen beta promoter is important for interleukin 6-induced expression, and its activity is influenced by the adjacent -148C/T polymorphism. J Biol Chem 280: 16763-16771, 2005
11. Merhi-Soussi F, Kwak BR, Magne D, Chadjichristos C, Berti M, Pelli G, James RW, Mach F, Gabay C: Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice. Cardiovasc Res 66: 583-589, 2005
12. Elhage R, Jawien J, Rudling M, Ljunggren HG, Takeda K, Akira S, Bayard F, Hansson GK: Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E knockout mice. Cardiovasc Res 59: 234-240, 2003
13. Nian M, Lee P, Khaper N, Liu P: Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 94: 1543-1553, 2004
14. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Fermo I, Foca A, Paroni R, Malatino LS: Inflammation is associated with carotid atherosclerosis in dialysis patients. J Hypertens 18: 1207-1213, 2000
15. Stenvinkel P, Heimburger O, Jogestrand T: Elevated interleukin-6 predicts progressive carotid artery atherosclerosis on dialysis patients: Association with Chlamydia pneumoniae seropositivity. Am J Kidney Dis 39: 274-282, 2002
16. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55: 648-658, 1999
17. Yeun JY, Levine RA, Mantadilok V, Kaysan GA: C-reactive protein predicts all cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35: 469-476, 2000
18. Kimmel PL, Phillips TM, Simmens SJ, Peterson RA, Weihs KL, Alleyne S, Cruz I, Yanovski JA, Veis JH: Immunological function and survival in hemodialysis patients. Kidney Int 54: 236-244, 1998
19. Stenvinkel P, Wanner C, Metzger T, Heimburger O, Mallamaci F, Tripepi G, Malatino LS, Zoccali C: Inflammation and outcome in end stage renal failure: Does female gender constitute a survival advantage? Kidney Int 62: 1791-1798, 2002
20. Papanicolaou DA, Wilder RL, Manolagas SC: Chrousos GP: The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 128: 127-137, 1998
21. Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FG: C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation 112: 976-983, 2005